Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-11-036967
Filing Date
2011-06-29
Accepted
2011-06-29 08:33:27
Documents
1
Period of Report
2011-06-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4971
  Complete submission text file 0001104659-11-036967.txt   6659
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BATTERY VENTURES 20 WILLIAM ST STE 200 WELLESLEY MA 02481
Business Address
TOBIN SCOTT R (Reporting) CIK: 0001199926 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17263 | Film No.: 11937252